Showing results (2381-2390 of 3,888) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|September 17, 2016
Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patientsZhengbo Song, Xinmin Yu, Yiping ZhangCancer Biology & Therapy|September 17, 2016
Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastomaAlexander Beck, Corinna Eberherr, Michaela Hagemann, et al.Cancer Biology & Therapy|February 13, 2010
Enhanced acute apoptotic response to azoxymethane-induced DNA damage in the rodent colonic epithelium by Tyrian purple precursors: a potential colorectal cancer chemopreventativeChantel B Westley, Cassandra M McIver, Catherine A Abbott, et al.Cancer Biology & Therapy|September 21, 2016
Single domain antibody-based bispecific antibody induces potent specific anti-tumor activityJing Li, Changhua Zhou, Bin Dong, et al.Cancer Biology & Therapy|August 2, 2018
Autophagy as a mechanism of Apo2L/TRAIL resistanceArishya Sharma, Alexandru AlmasanCancer Biology & Therapy|August 2, 2018
The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacyStephen L Wechman, Xiao-Mei Rao, Jorge G Gomez-Gutierrez, et al.Cancer Biology & Therapy|August 2, 2018
A fragment of SPARC reflecting increased collagen affinity shows pathological relevance in lung cancer - implications of a new collagen chaperone function of SPARCS N Kehlet, T Manon-Jensen, S Sun, et al.Cancer Biology & Therapy|August 2, 2018
Great efficacy of bevacizumab plus erlotinib for leptomeningeal metastases from non-small cell lung cancer with initially positive EGFR mutation: a case reportWang Jing, Haiyong Wang, Li Kong, et al.Cancer Biology & Therapy|August 8, 2018
CRMP4a suppresses cell motility by sequestering RhoA activity in prostate cancer cellsChanglin Li, Haixia Xu, Lin Xiao, et al.Cancer Biology & Therapy|August 11, 2018
A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinibYou-Cai Zhu, Wen-Xian Wang, Chun-Wei Xu, et al.Pageof 389